Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nivalis Therapeutics, Inc.

Home Clinical Trial Sponsors and OrganizationsNivalis Therapeutics, Inc.

Nivalis Therapeutics, Inc.

ACTIVE

科罗拉多州博尔德县, 科罗拉多州, United Stateswww.nivalis.comPrivate1–10 employeesEstablished: 2007-01-01

Part of Alpine Immune Sciences, Inc.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

11

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2007

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

9

81.8%

Phase 2

2

18.2%

Trial Status Distribution

Completed

10

90.9%

Unknown

1

9.1%

Clinical Trials

Trials sponsored by this organization (11)

MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9)

Oct 201632 participants

Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor

Apr 201619 participants

Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation

Nov 2015138 participants

A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

Jun 201515 participants

Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation

Feb 201551 participants

PK Study of N91115 in Cystic Fibrosis Patients

Oct 20146 participants

MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects

Feb 201449 participants

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Feb 201466 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials11
Approvals
News

Back to Organizations